login
login

Europe Daily Bulletin No. 12470

21 April 2020
EU RESPONSE TO COVID-19 / Health
Driven by industry, EU opts for regulatory flexibility
Brussels, 20/04/2020 (Agence Europe)

The European Union indicated on Monday 20 April that it had updated its regulatory adaptations to COVID-19, in particular with regard to good manufacturing practices (GMP) and safety checks. Regulatory flexibility is among the demands of the pharmaceutical industry, as evidenced by a webinar organised on the same day by the pharmaceutical industry lobby, EFPIA.

Regulatory framework opportunities activated

On 10 April, the Commission, the European Medicines Agency (EMA) and the Directors of...

Contents

EU RESPONSE TO COVID-19
SECTORAL POLICIES
EXTERNAL ACTION
ECONOMY - FINANCE - BUSINESS
INSTITUTIONAL
COUNCIL OF EUROPE
NEWS BRIEFS
Kiosk